Hostess Brands, Inc. (TWNK) Reaches $14.03 After 3.00% Up Move; ACURA PHARMACEUTICALS (ACUR) SI Increased By 4.12%

Sunday 1 July 2018

Hostess Brands, Inc. (TWNK) Reaches $14.03 After 3.00% Up Move; ACURA PHARMACEUTICALS (ACUR) SI Increased By 4.12%

The stock of Hostess Brands, Inc. (NASDAQ:TWNK) is a huge mover today! The stock increased 2.97% or $0.405 during the last trading session, reaching $14.025. About 393,000 shares traded. Hostess Brands, Inc. (NASDAQ:TWNK) has declined 17.15% since June 29, 2017 and is downtrending. It has underperformed by 29.72% the S&P500. Some Historical TWNK News: 09/05/2018 – Hostess Brands 1Q Rev $208.7M; 12/04/2018 – Hostess Chairman C. Dean Metropoulos Had Been Serving as Interim CEO, Will Remain Executive Chairman; 12/04/2018 – HOSTESS BRANDS, NAMES ANDREW CALLAHAN AS PRESIDENT & CEO; 26/03/2018 – Batter Up: Hostess Brands Launches Baseball CupCakes Just in Time for the Start of Baseball Season; 18/04/2018 – Hostess Brands Names Gretchen Crist to Board; 23/04/2018 – DJ Hostess Brands Inc Class A, Inst Holders, 1Q 2018 (TWNK); 18/04/2018 – Hostess Brands: Mark Stone Resigns From Board; 12/04/2018 – Hostess Brands, Inc. Names Andrew Callahan As President And Chief Executive Officer; 12/04/2018 – Andrew Callahan to Become Hostess CEO May; 09/05/2018 – HOSTESS BRANDS INC TWNK.O FY2018 SHR VIEW $0.69, REV VIEW $862.9 MLN — THOMSON REUTERS l/B/E/SThe move comes after 8 months positive chart setup for the $1.83 billion company. It was reported on Jun, 29 by Barchart.com. We have $14.45 PT which if reached, will make NASDAQ:TWNK worth $54.78 million more.

ACURA PHARMACEUTICALS INC (OTCMKTS:ACUR) had an increase of 4.12% in short interest. ACUR’s SI was 20,200 shares in June as released by FINRA. Its up 4.12% from 19,400 shares previously. With 16,900 avg volume, 1 days are for ACURA PHARMACEUTICALS INC (OTCMKTS:ACUR)’s short sellers to cover ACUR’s short positions. The SI to ACURA PHARMACEUTICALS INC’s float is 0.28%. The stock increased 33.06% or $0.119 during the last trading session, reaching $0.479. About 6,650 shares traded. Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) has 0.00% since June 29, 2017 and is . It has underperformed by 12.57% the S&P500.

More news for Hostess Brands, Inc. (NASDAQ:TWNK) were recently published by: Fool.com, which released: “2 Hated Stocks That Could Prove Everybody Wrong” on June 29, 2018. Nasdaq.com‘s article titled: “Market Trends Toward New Normal in Altria Group, WesBanco, NVR, Investors Real Estate Trust, Kaman, and Hostess …” and published on June 25, 2018 is yet another important article.

Analysts await Hostess Brands, Inc. (NASDAQ:TWNK) to report earnings on August, 14. They expect $0.18 EPS, 0.00% or $0.00 from last year’s $0.18 per share. TWNK’s profit will be $23.44M for 19.48 P/E if the $0.18 EPS becomes a reality. After $0.14 actual EPS reported by Hostess Brands, Inc. for the previous quarter, Wall Street now forecasts 28.57% EPS growth.

Hostess Brands, Inc., a packaged food company, focuses on developing, manufacturing, marketing, selling, and distributing fresh sweet baked goods in the United States. The company has market cap of $1.83 billion. The firm operates in two divisions, Sweet Baked Goods and Other. It has a 6.35 P/E ratio. The Company’s principal product lines include Twinkies, Zingers, Donettes, coffee cakes, cupcakes, cinnamon rolls, Ding Dongs, honey buns, fruit pies, Sno Balls, mini muffins, Chocodiles, Ho Hos, brownies, Suzy Qs, bread and buns, danishes, jumbo muffins, iced cookies, eclairs, and madeleines.

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products to address medication abuse and misuse. The company has market cap of $10.08 million. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. It currently has negative earnings. The firm has six additional opioid products in various stages of formulation development.

Hostess Brands, Inc. (NASDAQ:TWNK) Ratings Chart